Katrin Preller

Katrin Preller is one of the upcoming researchers, currently at the University of Zurich and Yale University, and is focused on the neurobiology and pharmacology of psychedelics.

CV

Katrin H. Preller, received her M.Sc. (Neuropsychology and Clinical Psychology) from the University of Konstanz, Germany. For her PhD, Dr. Preller joined the University of Zurich, Switzerland, where she investigated the neurobiological and social-cognitive long-term effects of cocaine, MDMA, and heroin use.

After completing her PhD, she joined the Neuropsychopharmacology and Brain Imaging Lab, investigating the effects of psychedelic substances on self-perception, social cognition, and multimodal processing using brain imaging techniques. Dr. Preller received an SNSF PostDoc mobility fellowship and worked as a Postdoc at the Wellcome Trust Centre for Neuroimaging, UCL, London, UK, and Yale University, New Haven, CT, USA.

Subsequently, she was appointed as Junior Group Leader at the University of Zurich and holds a position as Visiting Assistant Professor at Yale University. Her group’s research focus is centered on the neurobiology and pharmacology of cognitive and emotional processes in health and disease using multi-modal behavioral, electrophysiological, and neuroimaging techniques, the development of novel treatment approaches, and the interaction between pharmacological and non-pharmacological treatments.